COLL vs MAR · P/E 17, rev $181.9M vs P/E 32, rev $26.19B
Collegium Pharmaceutical Inc (COLL) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the COLL and MAR stock pages for the full models.
Not investment advice.